Lilly direct-selling Zepbound at $499/mo — compare with 11 other programs

Wegovy vs Zepbound

Editorial comparison of Wegovy (semaglutide) and Zepbound (tirzepatide). Same drug class context, trial-anchored data, no marketing claims.

Reviewed by the glpzoom Editorial Team against primary clinical sources — FDA labeling, peer-reviewed trials, and specialty-society guidelines.
Content current as of June 2026; updated when guidance or availability changes.

Side-by-side

DimensionWegovyZepbound
Generic namesemaglutidetirzepatide
ManufacturerNovo NordiskEli Lilly
FDA approved20212023
MechanismSemaglutide mimics GLP-1, a gut hormone released after meals.Tirzepatide is a dual incretin agonist: it hits both the GLP-1 receptor (like semaglutide) and the GIP receptor (which semaglutide doesn't).
DosingTitrated over 4-5 months: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg, increasing every 4 weeks.Titrated 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg, every 4 weeks. Maintenance 5-15mg weekly depending on tolerability and target weight.
CostList price ~$1,350/month without insurance.List price ~$1,000-1,300/month.
Pivotal trial result14.9% mean body-weight reduction at 68 weeks20.9% mean body-weight reduction at 72 weeks (15 mg dose)

Full Wegovy review →

Once-weekly injectable semaglutide for chronic weight management. ~15% body weight loss in trials.

Full Zepbound review →

Dual GLP-1/GIP agonist for weight management. ~20% body weight loss in trials — strongest weight-loss drug currently available.

Frequently asked

Is Wegovy or Zepbound more effective?+

In their pivotal trials, Wegovy reported 14.9% mean body-weight reduction at 68 weeks, while Zepbound reported 20.9% mean body-weight reduction at 72 weeks (15 mg dose). Head-to-head results vary by patient profile, dose tolerated, and adherence — these trial numbers describe averages, not what every individual experiences.

How do Wegovy and Zepbound compare on cost?+

Wegovy: List price ~$1,350/month without insurance. With Novo Nordisk's patient assistance program, eligible self-pay patients can access at $200-500/month. Insurance coverage is patchy and often requires prior authorization plus a documented weight-related comorbidity. Zepbound: List price ~$1,000-1,300/month. Lilly's patient assistance program (LillyDirect Self-Pay) offers $399-549/month for self-pay patients depending on dose. Insurance coverage similar pattern to Wegovy. Real out-of-pocket depends on insurance formulary tier, manufacturer savings programs, and whether a direct-pay channel is available.

Can I switch from Wegovy to Zepbound?+

Switching between brand-name treatments in the same drug class is common, but the conversion is not always 1:1. Discuss the switch with your prescriber — they'll usually re-titrate dosing rather than substitute equivalent strengths directly.

Are Wegovy and Zepbound the same drug?+

No. Wegovy (semaglutide) and Zepbound (tirzepatide) are distinct medications from Novo Nordisk and Eli Lilly respectively. They may share a drug class or mechanism but differ in active ingredient, dosing, and approved use.

We may earn a commission when you click links to partners. Affiliate disclosure.